跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
怡可安 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Canagliflozin Tablets
Approved
化学药品
Canagliflozin Tablets
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Apr 20, 2020
Approval ID
7MaoUHnCh92
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
7MaoUHnCh92
Approval Number
H20170374
Generic Name
卡格列净片
Generic Name En
Canagliflozin Tablets
Trade Name
怡可安
Drug Type
化学药品
Dosage Form
片剂
Strength
300mg(以卡格列净无水物(C₂₄H₂₅FO₅S)计)
Reg Date
2020-04-20
Expired Date
2025-04-19
Company Name
Janssen-Cilag International NV
Company Address
Turnhoutseweg 30, B-2340 Beerse, Belgium
Production Company Name
Janssen-Cilag SpA
Production Company Address
Via C. Janssen, Borgo San Michele, 04100 Latina, Italy
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/janssen-cilag-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 20, 2020
Approval ID
7MaoUHnCh92
Type
化学药品
Back to NMPA Approvals